Without a Prescription
The active component of Irinotecan is a widely known substance called Irinotecan. This and the other ingredients of this medical remedy make it one of the most commonly employed chemotherapy medicines; in other words, a therapy course with this product can be prescribed in the therapy of patients who are suffering from bowel cancer.
Numerous individuals from all over the world who have been diagnosed with a certain type of cancerous medical condition benefited from an intensive therapy course with Irinotecan. Most patients who have been prescribed a treatment trial with this medication were suffering from bowel cancer.
All individuals who are to employ a therapy course with this medication should be aware of the fact that their therapy trial with Irinotecan may increase their risk of developing thrombosis (blood clot). The symptoms of such a condition include redness, pain and swelling of one of the limbs (a leg, in general), chest pain, breathlessness, and so on. The presence of this condition is considered a medical emergency. As such, we strongly recommend all patients who develop any of these symptoms during their therapy trial with Irinotecan to alert their main clinical prescriber or the health care professional who is bound to monitor their treatment.
All female patients should know that an intensive intake of Irinotecan may affect their ability of becoming pregnant. Furthermore, the use of Irinotecan by male individuals may prevent them from being able to father a child. We recommend all patients who want to start using this medication to discuss all fertility-related issues with their physicians. All individuals with an active sexual life should employ an effective contraceptive method during their therapy with this product, and at least a couple of months after the end of their treatment, as if a pregnancy does arise during your use of Irinotecan, the baby is to present severe, irreversible harm.
Most individuals are administered their prescribed doses of Irinotecan as an infusion (a medical procedure also commonly referred to as a drip) through a special, fine tube (called by medical specialists a cannula). The IV administration of this product should be supervised by a well trained medical specialist. If you want to benefit to the full extent from your therapy's beneficial results you should make sure that you obey all of your physician's directions concerning your prescribed doses of this medication.
The average therapy span of one's use of Irinotecan involves several cycles (sessions) of treatment. For this reason, some individuals were administered this medication for several months. The length of one's therapy course with this anti-cancer medication depends on the type of cancer that the patient is suffering from, on the severity of the patient's condition, and so on. In most cases, the individual's therapy with Irinotecan is accompanied by the use of other chemotherapy medical remedies, as combination regimens are known to be the most effective therapeutic approach in such cases. You can discuss your therapy plan with your main medical prescriber.
All individuals are to be prescribed the correct Irinotecan dosing schedule by their main health care prescriber. Depending on the patient's response to his or her therapy course with this anti-cancer remedy, he or she may be prescribed a higher dose of this product. In other cases, the patient's current dose of Irinotecan may be diminished.
Over-dosage with this medication is uncommon, as the administration of a dose of Irinotecan is generally supervised by a well trained medical provider. In such cases, the patient must be immediately hospitalized, and he or she should be administered the adequate symptomatic / supportive therapeutic approach.
As most prescribed doses of Irinotecan should be administered under the strict supervision of the patient's main clinical prescriber, missed doses of this product are unlikely to disrupt one's therapy with this anti-cancer product (especially if the patient remains hospitalized during his or her therapy with this medication). For more information, study the drug's label.
Each individual is known to present a different reaction to their chemotherapy routine. While certain patients did not develop any severe symptoms (or developed only a few clinical manifestations), others have accused a wide variety of side effects due to their therapy course with Irinotecan. The most common clinical manifestations that may affect an individual who is following a chemotherapy session with this anti-cancerous medication include the symptoms of the acute cholinergic syndrome (diarrhea, stomach cramps, increased production of saliva, increased sweating, and so on). These symptoms occur due to an increase of the body's average increase of acetylcholine (a common chemical) and they develop during the administration of Irinotecan or within a day after it.
Such clinical conditions can be prevented and also kept under control with the help of another medical product, atropine. This medication is generally administered as a subcutaneous injection. In some cases, certain patients had to be administered more than one dose of atropine in order to deal with the side effects of Irinotecan.
All individuals must be well aware of the fact that their therapy trial with Irinotecan may be severely affected by the unauthorized use of other medical products as patients have suffered from a set of harmful consequences due to this matter. In some cases, even the use of herbal products, complementary therapies, and so on is not advised during one's treatment course with Irinotecan. The product's medical guide-book should contain further information concerning this matter.